EGFR and glioblastoma: Mass spectrometry analysis of five GBM cell lines revealed the upregulation of EGFR, CD44, PTPRJ, SLC1A5, F2R, and TSPAN6 proteins in these samples [12], whereby the expression level of these proteins was in concordance with our transcriptomics data analysis (Fig. 3).